摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(C6F5)2Pt(μ-PPh2)2Pt(CH3CN)2] | 881073-95-6

中文名称
——
中文别名
——
英文名称
[(C6F5)2Pt(μ-PPh2)2Pt(CH3CN)2]
英文别名
[(C6F5)2Pt(μ-P(C6H5)2)2Pt(acetonitrile)2];[(C6F5)2Pt(μ-PPh2)2Pt(NCCH3)2]
[(C<sub>6</sub>F<sub>5</sub>)<sub>2</sub>Pt(μ-PPh<sub>2</sub>)<sub>2</sub>Pt(CH<sub>3</sub>CN)<sub>2</sub>]化学式
CAS
881073-95-6
化学式
C40H26F10N2P2Pt2
mdl
——
分子量
1176.75
InChiKey
LMUUZOAFCZEWSV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    [(C6F5)2Pt(μ-PPh2)2Pt(CH3CN)2]二氯甲烷丙酮 为溶剂, 生成 [Pt4(μ-diphenylphosphido)3(μ3-P(C6H5)(1,2.-eta.2-C6H5-κ3P))(C6F5)4]
    参考文献:
    名称:
    An organometallic tetranuclear cluster with phosphine and phosphido ligands in nonclassical bonding modes: X-ray structural characterization
    摘要:
    The elimination of the NCMe ligand in [(C6F5)(2)Pt(mu-PPh2)(2)M(NCCH3)(2)] (M = Pd, Pt) results in the formation of the tetranuclear clusters [Pt2Pd2(p-PPh2)(3)(C6F5)(3)(PPh2C6F5)]1 and [Pt-4(mu-PPh2)(4)(C6F5)(4)](2). The structure of 1 indicates that one of the palladium centres is connected to the rest of the centres through two M-M bonds and two weaker eta(2) -C6H5 and eta(2) -P-C interactions. (c) 2006 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.jorganchem.2006.11.018
  • 作为产物:
    描述:
    (NBu4)2{(pentafluorophenyl)2platinum(II)(μ-diphenylphosphido)2platinum(II)(μ-Cl)2platinum(II)(μ-diphenylphosphido)2platinum(II)(pentafluorophenyl)2} 、 乙腈 在 AgClO4 作用下, 以 丙酮乙腈 为溶剂, 以76%的产率得到[(C6F5)2Pt(μ-PPh2)2Pt(CH3CN)2]
    参考文献:
    名称:
    双核磷铂 (II) 片段作为三核、四核、六核和八核复合物的构建块
    摘要:
    双核复合物 [(C6F5)2Pt(μ-PPh2)2Pt(NCCH3)2] (1) 被描述和充分表征。配合物 1 与 2,2'-双嘧啶和顺式-[M(C6F5)2(THF)2] 反应,分别形成二核、三核和四核配合物 2、3 和 4,具体取决于试剂和金属的类型 (M = Pt, Pd)。配合物 1 与 KCN 反应形成阴离子双核配合物 [PPh3(CH3)]2[(C6F5)2Pt(μ-PPh2)2Pt(CN)2] (6)。配合物 6 作为顺式-[M(C6F5)2(THF)2] 或 1 的金属配体产生相应的六核或八核配合物 7、8 和 9。 [PPh3(CH3)]4[{(C6F5) )2Pt(μ-PPh2)2Pt(μ-CN)2Pd(C6F5)2}2] (8) 已通过 X 射线衍射确定。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany
    DOI:
    10.1002/ejic.200500328
点击查看最新优质反应信息

文献信息

  • Behavior of Neutral Phosphido Derivatives of Platinum and Palladium toward Silver Centers
    作者:Juan Forniés、Consuelo Fortuño、Susana Ibáñez、Antonio Martín、Piero Mastrorilli、Vito Gallo
    DOI:10.1021/ic201354s
    日期:2011.11.7
    [(RF)2Pt(μ-PPh2)2M(P–P)] (P–P = 1,2-bis(diphenylphosphino)methane, dppm, M = Pt, 3; M = Pd, 4; P–P = 1,2-bis(diphenylphosphino)ethane, dppe, M = Pt, 5; M = Pd, 6) react with AgClO4 or [Ag(OClO3)(PPh3)], and the nature of the resulting complexes is dependent on both M and the diphosphine. The dppm Pt–Pt complex 3 reacts with [Ag(OClO3)(PPh3)], affording a silver adduct 10 in which the Ag atom interacts with
    中性双核配合物的反应[(R ˚F)2(μ-PPH 2)2 M(苯)](苯= 1,10-咯啉,R ˚F = C 6 ˚F 5 ; M = PT,1 ; M =,2)与AgClO 4或将[Ag(OCLO 3)(PPH 3)],得到三核配合物[AgPT 2(μ-PPH 2)2(R ˚F)2(苯)(OCLO 3)](图7a)或[AgPTM(μ-PPH 2)2(R ˚F)2(苯)(PPH 3)] [CLO 4 ](M = PT,8 ; M =,9),其显示“开卷”型结构和两个(图7a),或酮(8,9)的PT -键。中性二膦配合物[(R ˚F)2(μ-PPH 2)2 M(P-P)](P-P = 1,2-双(二苯基膦基甲烷DPPM,M = PT,3 ; M = Pd,4 ; P–P = 1,2-双(二苯基膦基乙烷,dppe,M = PT,5 ; M = Pd,6)与AgClO 4或[Ag(OClO
  • Formation of PPh<sub>2</sub>C<sub>6</sub>F<sub>5</sub> through Phosphido Platinum and/or Palladium(III) Intermediates<sup>,</sup>
    作者:Irene Ara、Naima Chaouche、Juan Forniés、Consuelo Fortuño、Abdelaziz Kribii、Athanassios C. Tsipis
    DOI:10.1021/om0508029
    日期:2006.2.1
    The two-electron oxidation reactions of the neutral [(C6F5)(2)M(mu-PR2)(2)M'(NCCH3)(2)] (M = M' = Pt or Pd, M = Pt, M' = Pd) complexes using I-2 as oxidant have been investigated by experimental (R = Ph) and electronic structure calculation methods (R = H). It was found that a reductive coupling of PR, and C6F5 takes place along the reaction pathway for all oxidized complexes. The most salient structural features of the [(C6F5)(2)Pt(mu-PR2)(2)Pd(C6F5)(2)](2-), [(C6F5)(2)Pd(mu-PR2)(2)Pd(acac)](-), and [(C6F5)(2)Pt(mu-PR2)(2)PtI2] complexes (experimental R = Ph) are reproduced very well by the B3LYP/lan12dz calculations (R = H).
  • From a di- and trinuclear phosphanido fragment to tetra- and hexanuclear platinum(II) complexes
    作者:Andersson Arias、Juan Forniés、Consuelo Fortuño、Antonio Martín
    DOI:10.1016/j.ica.2013.07.048
    日期:2013.10
    The di-and trinuclear derivatives [(RF)(2)Pt(mu-PPh2)(2)Pt(CH3CN)(2)], 1, [(RF)(2)Pt(mu-PPh2)(2)Pt(mu-PPh2)(2)Pt(CH3 CN)(2)], 2, (RF = C6F5) behave as synthons of di-and trinuclear fragments. Addition of azide and oxalate ions to 1 and 2, even in an excess, provides a way to isolate the tetranuclear and hexanuclear platinum complexes [NBu4](2)[(RF)(2)Pt(mu-PPh2)(2)Pt}(n)(mu-1,1-N-3)}(2)] (n = 1, 3; 2, 5), [NBu4](2)[(RF)(2)Pt(mu-PPh2)(2)Pt}(2)(mu-C2O4-kappa O-2, O': kappa O-2 '', O ''')}], 4, and [NBu4](2)[(RF)(2)Pt(mu-PPh2)(2)Pt(mu-PPh2)(2)Pt}(2)(mu-C2O4-kappa O-2, O': kappa O-2 '', O ''')}], 6. The structures of 3-6, determined by single crystal X-ray diffraction, show a linear arrangement of the platinum centres maintained through "Pt(mu-PPh2)(2)Pt" and "Pt(mu-1,1-N-3)(2)Pt" or "Pt(mu-C2O4-kappa O-2, O': kappa O-2 '', O ''') Pt" bridging fragments. Finally, addition of KCN to 2 affords the trinuclear [NBu4](2)[(RF)(2) Pt(mu-PPh2)(2)Pt(mu-PPh2)(2)Pt(CN)(2)], 7, in which two cyanido groups are bonded to the platinum centre in a terminal way. (C) 2013 Elsevier B.V. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫